T0	Interventions 0 22	Phosphorylated p-70S6K
T1	Interventions 32 41	tamoxifen
T2	Interventions 122 131	tamoxifen
T3	Interventions 139 161	no systemic treatment.
T4	Interventions 194 230	phosphatidylinositol-3-kinase (PI3K)
T5	Interventions 238 277	mitogen-activated protein kinase (MAPK)
T6	Interventions 492 509	endocrine therapy
T7	Interventions 549 566	rapamycine (mTOR)
T8	Interventions 637 665	adjuvant endocrine treatment
T9	Interventions 962 971	tamoxifen
T10	Interventions 1133 1183	adjuvant tamoxifen (1-3 years) versus observation.
T11	Interventions 1205 1223	tissue micro-array
T12	Interventions 1486 1499	and tamoxifen
T13	Interventions 1557 1623	between tamoxifen and p-AKT(Thr308), p-mTOR, p-p70S6K and p-ERK1/2
T14	Interventions 1672 1680	p-p70S6K
T15	Interventions 1715 1729	with tamoxifen
T16	Interventions 1809 1823	from tamoxifen
T17	Interventions 2230 2248	adjuvant tamoxifen